Argent
Advancing Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies
As a partner in the four-year ARGENT project, Minerva has provided training activities for Early Stage Researchers (ESRs), to deliver impact through stakeholder engagement, media communications and public outreach.
The FP7 European Multi-ITN (Marie Curie Actions Initial Training Network) project ‘Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies (ITN ARGENT)’, started in March 2014.
Cancer is the second most common form of death after cardiovascular disease, and is a major European health concern. The main objective of this intersectional and multidisciplinary ITN is to create a new generation of researches and experts able to create the platform on which next-generation cancer therapy will be built.
The consortium aims to train a cohort of 13 PhDs (Early Stage Researchers) to subsequently act as leaders and ambassadors in the field. The ITN ARGENT strategy relies on improving our understanding of the processes and mechanisms.
